BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 15854241)

  • 1. Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.
    Chang EL; Selek U; Hassenbusch SJ; Maor MH; Allen PK; Mahajan A; Sawaya R; Woo SY
    Neurosurgery; 2005 May; 56(5):936-45; discussion 936-45. PubMed ID: 15854241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
    Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
    Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.
    Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC
    Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
    Clarke JW; Register S; McGregor JM; Grecula JC; Mayr NA; Wang JZ; Li K; Gupta N; Kendra KL; Olencki TE; Cavaliere R; Sarkar A; Lo SS
    Am J Clin Oncol; 2010 Feb; 33(1):70-4. PubMed ID: 19652578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397).
    Manon R; O'Neill A; Knisely J; Werner-Wasik M; Lazarus HM; Wagner H; Gilbert M; Mehta M;
    J Clin Oncol; 2005 Dec; 23(34):8870-6. PubMed ID: 16314647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases.
    Kano H; Iyer A; Kondziolka D; Niranjan A; Flickinger JC; Lunsford LD
    Neurosurgery; 2011 Dec; 69(6):1232-9. PubMed ID: 21716155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma.
    Muacevic A; Kreth FW; Mack A; Tonn JC; Wowra B
    Minim Invasive Neurosurg; 2004 Aug; 47(4):203-8. PubMed ID: 15346315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
    Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
    Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINAC radiosurgery for brain metastasis of renal cell carcinoma.
    Noel G; Valery CA; Boisserie G; Cornu P; Hasboun D; Marc Simon J; Tep B; Ledu D; Delattre JY; Marsault C; Baillet F; Mazeron JJ
    Urol Oncol; 2004; 22(1):25-31. PubMed ID: 14969800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
    Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
    Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma knife radiosurgery for malignant melanoma brain metastases.
    Seung SK; Sneed PK; McDermott MW; Shu HK; Leong SP; Chang S; Petti PL; Smith V; Verhey LJ; Wara WM; Phillips TL; Larson DA
    Cancer J Sci Am; 1998; 4(2):103-9. PubMed ID: 9532412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases.
    Scorsetti M; Facoetti A; Navarria P; Bignardi M; De Santis M; Ninone SA; Lattuada P; Urso G; Vigorito S; Mancosu P; Del Vecchio M
    Anticancer Res; 2009 Oct; 29(10):4259-63. PubMed ID: 19846983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma Knife surgery in the management of radioresistant brain metastases in high-risk patients with melanoma, renal cell carcinoma, and sarcoma.
    Powell JW; Chung CT; Shah HR; Canute GW; Hodge CJ; Bassano DA; Liu L; Mitchell L; Hahn SS
    J Neurosurg; 2008 Dec; 109 Suppl():122-8. PubMed ID: 19123898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
    Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
    Neurosurgery; 2008 Feb; 62 Suppl 2():790-801. PubMed ID: 18596426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma knife radiosurgery in the management of malignant melanoma brain metastases.
    Mathieu D; Kondziolka D; Cooper PB; Flickinger JC; Niranjan A; Agarwala S; Kirkwood J; Lunsford LD
    Neurosurgery; 2007 Mar; 60(3):471-81; discussion 481-2. PubMed ID: 17327791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosurgery for brain metastases from primary lung carcinoma.
    Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
    Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery for four or more intracranial metastases.
    Bhatnagar AK; Flickinger JC; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):898-903. PubMed ID: 16338097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.
    DiLuna ML; King JT; Knisely JP; Chiang VL
    Cancer; 2007 Jan; 109(1):135-45. PubMed ID: 17133440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.